Q3 2025 Holdings
Filed 2025-11-14 | 194 holdings | $2.6B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $145.9M | 2,454,797 | 5.6% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $143.8M | 4,151,194 | 5.5% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $125.2M | 11,329,500 | 4.8% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $92.1M | 1,500,000 | 3.5% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $90.6M | 1,236,027 | 3.5% |
| Kiniksa Pharmaceuticals Intl(KNSA) | ORD SHS CL A | G52694109 | $90.4M | 2,328,609 | 3.5% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $83.8M | 2,305,608 | 3.2% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $61.4M | 5,041,798 | 2.4% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $61.4M | 2,842,925 | 2.4% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $58.8M | 16,811,963 | 2.3% |
| Celcuity Inc(CELC) | COM | 15102K100 | $56.8M | 1,150,000 | 2.2% |
| Merus N V | COM | N5749R100 | $56.5M | 600,000 | 2.2% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $53.6M | 3,200,000 | 2.1% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $42.1M | 8,068,058 | 1.6% |
| Lenz Therapeutics Inc(LENZ) | COM | 52635N103 | $41.8M | 897,616 | 1.6% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $40.8M | 1,333,639 | 1.6% |
| Precigen Inc(PGEN) | COM | 74017N105 | $40.8M | 12,400,000 | 1.6% |
| Vera Therapeutics Inc CL A(VERA) | CL A | 92337R101 | $39.2M | 1,350,000 | 1.5% |
| Nike Inc(NKE) | CL B | 654106103 | $36.2M | 519,399 | 1.4% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $36.0M | 550,000 | 1.4% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $35.3M | 11,065,662 | 1.4% |
| Evolus Inc(EOLS) | COM | 30052C107 | $33.7M | 5,488,299 | 1.3% |
| Avadel Pharmaceuticals PLC | COM SHS | G29687103 | $32.0M | 2,097,500 | 1.2% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $32.0M | 1,500,000 | 1.2% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $31.3M | 80,000 | 1.2% |
| ANI Pharmaceuticals Inc(ANIP) | COM | 00182C103 | $29.1M | 317,500 | 1.1% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $28.8M | 200,000 | 1.1% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $27.1M | 830,000 | 1.0% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $26.6M | 270,000 | 1.0% |
| Liquidia Corporation(LQDA) | COM NEW | 53635D202 | $26.0M | 1,143,759 | 1.0% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $25.0M | 190,000 | 1.0% |
| Nvidia Corporation(NVDA) | COM | 67066G104 | $24.4M | 130,509 | 0.9% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $22.9M | 870,000 | 0.9% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $22.4M | 1,418,984 | 0.9% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $21.1M | 150,000 | 0.8% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $20.0M | 1,000,000 | 0.8% |
| Dynavax Technologies Corp(DVAX) | COM NEW | 268158201 | $19.4M | 1,949,500 | 0.7% |
| Meta Platforms Inc(META) | CL A | 30303M102 | $19.1M | 26,008 | 0.7% |
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $18.8M | 1,100,000 | 0.7% |
| GSK PLC(GSK) | SPONSORED ADR | 37733W204 | $17.3M | 400,000 | 0.7% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $17.1M | 700,000 | 0.7% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $16.7M | 700,000 | 0.6% |
| Nuvation BIO Inc(NUVB) | COM CL A | 67080N101 | $15.5M | 4,200,000 | 0.6% |
| Adma Biologics Inc(ADMA) | COM | 000899104 | $15.4M | 1,050,000 | 0.6% |
| Nkarta Inc(NKTX) | COM | 65487U108 | $14.6M | 7,055,576 | 0.6% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $14.2M | 3,400,000 | 0.5% |
| Atea Pharmaceuticals Inc(AVIR) | COM | 04683R106 | $14.0M | 4,826,200 | 0.5% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $13.4M | 1,780,975 | 0.5% |
| Journey MED Corp(DERM) | COM | 48115J109 | $13.2M | 1,854,596 | 0.5% |
| Abcellera Biologics Inc(ABCL) | COM | 00288U106 | $13.1M | 2,600,000 | 0.5% |